EMPATHX CLINICAL RESEARCH Trademark

Trademark Overview

On Thursday, June 8, 2023, a trademark application was filed for EMPATHX CLINICAL RESEARCH with the United States Patent and Trademark Office. The USPTO has given the EMPATHX CLINICAL RESEARCH trademark a serial number of 98032971. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Tuesday, June 2, 2026. This trademark is owned by American Clinical Research Services Holdings, LLC. The EMPATHX CLINICAL RESEARCH trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

medical and scientific research, namely, conducting clinical trials for others

General Information

Serial Number98032971
Word MarkEMPATHX CLINICAL RESEARCH
Filing DateThursday, June 8, 2023
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateTuesday, June 2, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements

Goods and Servicesmedical and scientific research, namely, conducting clinical trials for others
NOT AVAILABLE"CLINICAL RESEARCH"

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, July 12, 2023
Primary Code042
First Use Anywhere DateThursday, January 29, 2026
First Use In Commerce DateThursday, January 29, 2026

Trademark Owner History

Party NameAmerican Clinical Research Services Holdings, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDallas, TX 75201
US
Party NameAmerican Clinical Research Services Holdings, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDallas, TX 75201
US

Trademark Events

Event DateEvent Description
Monday, June 12, 2023NEW APPLICATION ENTERED
Wednesday, July 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 29, 2024ASSIGNED TO EXAMINER
Thursday, February 29, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, February 29, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, February 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 29, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, February 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 23, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 23, 2024SOU EXTENSION 1 FILED
Wednesday, October 23, 2024SOU EXTENSION 1 GRANTED
Wednesday, October 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 9, 2025SOU TEAS EXTENSION RECEIVED
Friday, May 9, 2025SOU EXTENSION 2 FILED
Saturday, May 10, 2025SOU EXTENSION 2 GRANTED
Saturday, May 10, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 6, 2025SOU TEAS EXTENSION RECEIVED
Thursday, November 6, 2025SOU EXTENSION 3 FILED
Thursday, November 6, 2025SOU EXTENSION 3 GRANTED
Friday, November 7, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 10, 2026TEAS STATEMENT OF USE RECEIVED
Tuesday, February 10, 2026USE AMENDMENT FILED
Wednesday, June 3, 2026STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

research clinical empathx trials others conducting namely scientific medical